| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.00025 | 1 |